ARTICLE | Clinical News
Medicines Co. discontinues MDCO-2010
October 6, 2012 12:38 AM UTC
The Medicines Co. (NASDAQ:MDCO) discontinued MDCO-2010 after seeing "serious" safety issues in a Phase IIb trial of the small molecule serine protease inhibitor to reduce blood loss during surgery. Medicines Co. declined to disclose details of the issues, but said it plans to publish the full data at a later date. ...